Nano-Cap Nexalin Technology Secures US Patent For Stimulation Device For Alzheimer's And Dementia Treatment [Yahoo! Finance]
Nexalin Technology, Inc. (NXL)
Company Research
Source: Yahoo! Finance
Patent No 12,011,591 to the company's noninvasive Deep Intracranial Frequency Stimulation (DIFS) medical device, which is used to treat Alzheimer's and other dementia-related brain diseases. The patent was awarded on June 18. The newly issued patent, “Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method for Alzheimer's and Dementia,” relates to the company's Gen-2 and Gen-3 brain stimulation medical device. Nexalin told that the device administers a proprietary frequency-based waveform that is designed to treat patients in a pain-free and undetectable manner. Mark White, CEO of Nexalin Technology, stated, “According to Grandview Research, the global dementia treatment market is estimated to be in excess of $18 billion and is projected to reach over $28 billion by 2030...According to the World Health Organization, more than 55 million people currently live with dementia, and nearly 10 million new cases are diagnosed every year. The market is further bols
Show less
Read more
Impact Snapshot
Event Time:
NXL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NXL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NXL alerts
High impacting Nexalin Technology, Inc. news events
Weekly update
A roundup of the hottest topics
NXL
News
- Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid TreatmentGlobeNewswire
- Nexalin Technology Second Quarter 2024 Earnings: US$0.17 loss per share (vs US$0.11 loss in 2Q 2023) [Yahoo! Finance]Yahoo! Finance
- Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV [Yahoo! Finance]Yahoo! Finance
- Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVAccesswire
- Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery [Yahoo! Finance]Yahoo! Finance
NXL
Sec Filings
- 9/25/24 - Form 4
- 9/25/24 - Form 4/A
- 9/25/24 - Form 8-K
- NXL's page on the SEC website